| 1 | Neurogenic bladder in spinal cord injury patients (10.2147/rru.s29644) | Abstract References ORCID | 153.40 | 110 |
| 2 | Review of the epidemiology of overactive bladder (10.2147/rru.s102441) | Abstract References ORCID | 138.38 | 69 |
| 3 | Inflammatory mechanisms and oxidative stress in prostatitis:… (10.2147/rru.s170400) | Abstract References ORCID | 128.70 | 51 |
| 4 | Immunotherapy for bladder cancer (10.2147/rru.s63447) | Abstract References ORCID | 128.07 | 50 |
| 5 | Two-year results after convective radiofrequency water vapor… (10.2147/rru.s119596) | Abstract References ORCID | 126.76 | 48 |
| 6 | Procedural techniques and multicenter postmarket experience… (10.2147/rru.s143679) | Abstract References ORCID | 120.96 | 40 |
| 7 | Efficacy and safety of the phytotherapeutic drug Canephron&a… (10.2147/rru.s39288) | Abstract References ORCID | 111.85 | 30 |
| 8 | Novel targeted bladder drug-delivery systems: a review (10.2147/rru.s56168) | Abstract References ORCID | 110.78 | 29 |
| 9 | Evaluation and management of overactive bladder: strategies… (10.2147/rru.s93636) | Abstract References ORCID | 109.68 | 28 |
| 10 | Enzalutamide and blocking androgen receptor in advanced pros… (10.2147/rru.s157116) | Abstract References ORCID | 108.54 | 27 |
| 11 | Role of duration of catheterization and length of hospital s… (10.2147/rru.s75419) | Abstract References ORCID | 108.54 | 27 |
| 12 | Transurethral convective water vapor as a treatment for lowe… (10.2147/rru.s74040) | Abstract References ORCID | 107.35 | 26 |
| 13 | Managing the adverse events of intravesical bacillus Calmett… (10.2147/rru.s63448) | Abstract References ORCID | 104.85 | 24 |
| 14 | Prevention and management of urosepsis triggered by ureteros… (10.2147/rru.s128071) | Abstract References ORCID | 102.13 | 22 |
| 15 | Sacral neuromodulation in overactive bladder: a review and c… (10.2147/rru.s89544) | Abstract References ORCID | 100.68 | 21 |
| 16 | Digital ureteroscopes: technology update (10.2147/rru.s104229) | Abstract References ORCID | 92.28 | 16 |
| 17 | Association of prostate volume with incidence and aggressive… (10.2147/rru.s117963) | Abstract References ORCID | 92.28 | 16 |
| 18 | The conceptualization and development of a patient-reported… (10.2147/rru.s51020) | Abstract References ORCID | 92.28 | 16 |
| 19 | Efficacy and safety evaluation of pentoxifylline associated… (10.2147/rru.s97194) | Abstract References ORCID | 92.28 | 16 |
| 20 | Management of urinary tract infections in patients with neur… (10.2147/rru.s113610) | Abstract References ORCID | 90.31 | 15 |
| 21 | Microtubule-associated protein tau is associated with the re… (10.2147/rru.s118966) | Abstract References ORCID | 88.21 | 14 |
| 22 | Review of techniques for ultrasonic determination of kidney… (10.2147/rru.s128039) | Abstract References ORCID | 88.21 | 14 |
| 23 | Long-term effects of pediatric extracorporeal shockwave lith… (10.2147/rru.s40965) | Abstract References ORCID | 88.21 | 14 |
| 24 | A review of the epidemiology and treatment of Peyronie&#… (10.2147/rru.s65620) | Abstract References ORCID | 88.21 | 14 |
| 25 | Integrating diet and exercise into care of prostate cancer p… (10.2147/rru.s107852) | Abstract References ORCID | 85.96 | 13 |
| 26 | The role of inflammatory mediators in the development of pro… (10.2147/rru.s23386) | Abstract References ORCID | 85.96 | 13 |
| 27 | Clinical use of alprostadil topical cream in patients with e… (10.2147/rru.s68560) | Abstract References ORCID | 83.55 | 12 |
| 28 | Results of a randomized, prospective, double-dummy, double-b… (10.2147/rru.s121203) | Abstract References ORCID | 80.94 | 11 |
| 29 | Optimal management of muscle-invasive bladder cancer &nd… (10.2147/rru.s73566) | Abstract References ORCID | 80.94 | 11 |
| 30 | Autologous pubovaginal slings: back to the future or a lost… (10.2147/rru.s96957) | Abstract References ORCID | 80.94 | 11 |
| 31 | Prevalence, psychological impact, and risk factors of erecti… (10.2147/rru.s109319) | Abstract References ORCID | 78.10 | 10 |
| 32 | Prostatic artery embolization versus transurethral resection… (10.2147/rru.s139086) | Abstract References ORCID | 78.10 | 10 |
| 33 | IL-8 secretion in primary cultures of prostate cells is asso… (10.2147/rru.s58643) | Abstract References ORCID | 78.10 | 10 |
| 34 | Management of erectile dysfunction post-radical prostatectom… (10.2147/rru.s58974) | Abstract References ORCID | 78.10 | 10 |
| 35 | <p>Urinary Microbiome Evaluation in Patients Presentin… (10.2147/rru.s233386) | Abstract References ORCID | 75.00 | 9 |
| 36 | Clinical use of abiraterone in the treatment of metastatic c… (10.2147/rru.s29003) | Abstract References ORCID | 75.00 | 9 |
| 37 | Therapeutic efficacy and anti-inflammatory effect of ramelte… (10.2147/rru.s44502) | Abstract References ORCID | 75.00 | 9 |
| 38 | Obstructive renal injury: from fluid mechanics to molecular… (10.2147/rru.s6597) | Abstract References ORCID | 75.00 | 9 |
| 39 | Detection of AR-V7 mRNA in whole blood may not predict the e… (10.2147/rru.s98877) | Abstract References ORCID | 75.00 | 9 |
| 40 | Intramuscular depot formulations of leuprolide acetate suppr… (10.2147/rru.s111475) | Abstract References ORCID | 71.57 | 8 |
| 41 | Social, economic, and health utility considerations in the t… (10.2147/rru.s4166) | Abstract References ORCID | 71.57 | 8 |
| 42 | A comparison of robotic arm versus gantry linear accelerator… (10.2147/rru.s58262) | Abstract References ORCID | 71.57 | 8 |
| 43 | Effectiveness of percutaneous tibial nerve stimulation in th… (10.2147/rru.s124981) | Abstract References | 70.75 | 25 |
| 44 | Urothelial carcinoma: the evolving landscape of immunotherap… (10.2147/rru.s125635) | Abstract References ORCID | 67.73 | 7 |
| 45 | Distinguishing testicular torsion from torsion of the append… (10.2147/rru.s140361) | Abstract References ORCID | 67.73 | 7 |
| 46 | Redo hypospadias surgery: current and novel techniques (10.2147/rru.s142989) | Abstract References ORCID | 67.73 | 7 |
| 47 | Role of biochemical markers in testicular cancer: diagnosis,… (10.2147/rru.s15063) | Abstract References ORCID | 67.73 | 7 |
| 48 | Detection of low frequency FGFR3 mutations in the urine of b… (10.2147/rru.s32736) | Abstract References ORCID | 67.73 | 7 |
| 49 | Pharmacotherapy of overactive bladder in adults: a review of… (10.2147/rru.s40034) | Abstract References ORCID | 67.73 | 7 |
| 50 | OnabotulinumtoxinA for the treatment of overactive bladder (10.2147/rru.s43125) | Abstract References ORCID | 67.73 | 7 |